Cynthia Seidel-Dugan
Keine laufenden Positionen mehr
Vermögen: 1 Mio $ am 31.03.2024
Karriereverlauf von Cynthia Seidel-Dugan
Ehemalige bekannte Positionen von Cynthia Seidel-Dugan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.04.2019 | 29.03.2024 |
Potenza Therapeutics, Inc.
 Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.05.2014 | 01.12.2018 |
CoStim Pharmaceuticals, Inc.
 CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.05.2013 | 01.02.2014 |
Ausbildung von Cynthia Seidel-Dugan
| University of Pennsylvania | Doctorate Degree |
| The College of William & Mary | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| WEREWOLF THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Cynthia Seidel-Dugan
- Erfahrung
